1
|
He Q, Yu CF, Wu G, Wang KQ, Ni YB, Guo X, Fu ZH, Wang L, Tan DJ, Gao H, Wang C, Chen G, Chen XH, Chen B, Wang JZ. A novel alternative for pyrogen detection based on a transgenic cell line. Signal Transduct Target Ther 2024; 9:33. [PMID: 38369543 PMCID: PMC10874988 DOI: 10.1038/s41392-024-01744-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Revised: 10/07/2023] [Accepted: 01/10/2024] [Indexed: 02/20/2024] Open
Abstract
Pyrogen, often as a contaminant, is a key indicator affecting the safety of almost all parenteral drugs (including biologicals, chemicals, traditional Chinese medicines and medical devices). It has become a goal to completely replace the in vivo rabbit pyrogen test by using the in vitro pyrogen test based on the promoted 'reduction, replacement and refinement' principle, which has been highly considered by regulatory agencies from different countries. We used NF-κB, a central signalling molecule mediating inflammatory responses, as a pyrogenic marker and the monocyte line THP-1 transfected with a luciferase reporter gene regulated by NF-κB as an in vitro model to detect pyrogens by measuring the intensity of a fluorescence signal. Here, we show that this test can quantitatively and sensitively detect endotoxin (lipopolysaccharide from different strains) and nonendotoxin (lipoteichoic acid, zymosan, peptidoglycan, lectin and glucan), has good stability in terms of NF-κB activity and cell phenotypes at 39 cell passages and can be applied to detect pyrogens in biologicals (group A & C meningococcal polysaccharide vaccine; basiliximab; rabies vaccine (Vero cells) for human use, freeze-dried; Japanese encephalitis vaccine (Vero cells), inactivated; insulin aspart injection; human albumin; recombinant human erythropoietin injection (CHO Cell)). The within-laboratory reproducibility of the test in three independent laboratories was 85%, 80% and 80% and the interlaboratory reproducibility among laboratories was 83.3%, 95.6% and 86.7%. The sensitivity (true positive rate) and specificity (true negative rate) of the test were 89.9% and 90.9%, respectively. In summary, the test provides a novel alternative for pyrogen detection.
Collapse
Affiliation(s)
- Qing He
- National Institutes for Food and Drug Control, Beijing, China
| | - Chuan-Fei Yu
- National Institutes for Food and Drug Control, Beijing, China
| | - Gang Wu
- School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China
| | - Kai-Qin Wang
- National Institutes for Food and Drug Control, Beijing, China
| | - Yong-Bo Ni
- National Institutes for Food and Drug Control, Beijing, China
| | - Xiao Guo
- National Institutes for Food and Drug Control, Beijing, China
| | - Zhi-Hao Fu
- National Institutes for Food and Drug Control, Beijing, China
| | - Lan Wang
- National Institutes for Food and Drug Control, Beijing, China
| | - De-Jiang Tan
- National Institutes for Food and Drug Control, Beijing, China
| | - Hua Gao
- National Institutes for Food and Drug Control, Beijing, China
| | - Can Wang
- Shanghai Institute for Food and Drug Control, Shanghai, China
| | - Gang Chen
- Shanghai Institute for Food and Drug Control, Shanghai, China
| | | | - Bo Chen
- KeyMed Biosciences Inc., Chengdu, China
| | - Jun-Zhi Wang
- National Institutes for Food and Drug Control, Beijing, China.
| |
Collapse
|
2
|
Han Q, Hu R, Li H, Lei Z, Zhang X, Yu X, Zhang Q, Mao Y, Wang X, Irwin DM, Niu G, Tan H. Application of a TLR overexpression cell model in pyrogen detection. Biotechnol Bioeng 2019; 116:1269-1279. [PMID: 30684361 PMCID: PMC6519253 DOI: 10.1002/bit.26936] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2018] [Revised: 01/17/2019] [Accepted: 01/22/2019] [Indexed: 12/20/2022]
Abstract
Pyrogens are components derived from microorganisms that induce complex inflammatory responses. Current approaches to detect pyrogens are complex and difficult to replicate, thus there is a need for new methods to detect pyrogens. We successfully constructed a pyrogen-sensitive cell model by overexpressing Toll-like receptor (TLR)2, TLR4, MD2, and CD14 in HEK293 cells. Since the cytokine IL-6 is specifically released upon stimulation of the TLR2 and TLR4 signaling pathways in response to pyrogen stimulation, we used it as a read out for our assay. Our results show that IL-6 is released in response to trace amounts of pyrogens in our cell model. Pyrogen incubation times and concentrations were explored to determine the sensitivity of our cell model, and was found to be sensitive to 0.05 EU/ml of LPS and 0.05 ug/ml of LTA after stimulation for 5 hr. Our TLR overexpressing cell model, with IL-6 as readout, could be a new method for in vitro testing of pyrogens and applicable for evaluating the safety of drugs.
Collapse
Affiliation(s)
- Qing Han
- Department of PharmacologyPeking University, Health Science CenterBeijingChina
| | - Ruobi Hu
- Department of PharmacologyPeking University, Health Science CenterBeijingChina
| | - Hui Li
- Department of PharmacologyPeking University, Health Science CenterBeijingChina
| | - Zhen Lei
- Research and Development DepartmentBeijing N&N Genetech CompanyBeijingChina
| | - Xuehui Zhang
- Department of PharmacologyPeking University, Health Science CenterBeijingChina
| | - Xiuyan Yu
- Department of PharmacologyPeking University, Health Science CenterBeijingChina
| | - Qun Zhang
- Department of PharmacologyPeking University, Health Science CenterBeijingChina
| | - Yiqing Mao
- Department of PharmacologyPeking University, Health Science CenterBeijingChina
| | - Xi Wang
- Department of PharmacologyPeking University, Health Science CenterBeijingChina
| | - David M. Irwin
- Department of PharmacologyPeking University, Health Science CenterBeijingChina
- Department of Laboratory Medicine and PathobiologyUniversity of Toronto, TorontoOntarioCanada
| | - Gang Niu
- Research and Development DepartmentBeijing N&N Genetech CompanyBeijingChina
| | - Huanran Tan
- Department of PharmacologyPeking University, Health Science CenterBeijingChina
| |
Collapse
|